GRFS$8.100.75%0.06
Grifols Sa Adr (GRFS)
Date: 2026-10-30 16:00O: 8.10H: 8.25L: 8.05C: 8.10Vol: 803.4k
Grifols Sa Adr stock is traded at $8.10, with a volume of 803,383. It is up +0.75% in the last 24 hours and up +10.81% over the past month. Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
Previous Close:
$8.04
Open:
$8.10
24h Volume:
803,383
Relative Volume:
1.09
Market Cap:
$5.51B
Revenue:
$8.62B
Net Income/Loss:
$573.80M
P/E Ratio:
11.46
EPS:
$0.707
Net Cash Flow:
$680.05M
1W Performance:
+7.14%
1M Performance:
+10.81%
6M Performance:
-1.70%
1Y Performance:
-11.57%
1-Day Range:
$8.05$8.25
1-Week Range:
$7.76$8.30
52-Week Range:
$6.96$9.90
Grifols Sa Adr Stock (GRFS) Company Profile
Compare GRFS vs LLY, JNJ, ABBV, MRK, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRFS Grifols Sa Adr | $8.10 | $5.51B | $8.62B | $573.80M | $680.05M | $0.707 |
 LLY Lilly Eli Co | $1,417.54 | $1.26T | $72.25B | $25.28B | $10.37B | $27.78 |
 JNJ Johnson Johnson | $273.20 | $657.68B | $97.93B | $21.04B | $17.80B | $8.63 |
 ABBV Abbvie Inc | $294.89 | $521.11B | $62.82B | $3.60B | $19.98B | $2.03 |
 MRK Merck Co Inc | $149.52 | $368.89B | $65.51B | $8.93B | $14.12B | $3.55 |
 NVS Novartis Ag Adr | $160.79 | $303.67B | $54.66B | $13.58B | $16.05B | $7.02 |
